Four Decades for Justice
March 24, 2015
Cravath represented the initial servicer, Mylan Pharmaceuticals Inc., and seller, Mylan Securitization LLC, a wholly owned special purpose subsidiary of Mylan Pharmaceuticals Inc., in connection with their $400 million accounts receivable securitization facility. The transaction closed on January 27, 2015.
The Cravath team included partner George E. Zobitz and associate C. Daniel Haaren on banking matters; associate Chase A. M. Proctor on structured finance and securitization matters; and partner J. Leonard Teti II and associates Stephen R. Severo and Peter W. Rogers on tax matters. Caitlin M. Hyduke also worked on banking matters and Kiran Sheffrin also worked on tax matters.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.